Zydus Lifesciences announced on Monday that it has introduced a generic drug to treat overactive ... Mirabegron extended-release tablets (USP 25mg and 50mg) had yearly sales of USD 2.42 billion ...
Some results have been hidden because they may be inaccessible to you